ImmuCell Corporation (NASDAQ:ICCC) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02 – Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
On August 10, 2017, Dr. Linda Rhodes gave notice of her resignation from her position on the Company’s Board of Directors effective immediately.
Dr. Rhodes was thanked for her dedicated service to the Company since 2005.
Item 9.01 –Financial Statements and Exhibits.
| (d) | Exhibits. |
| The Exhibits included as part of this Current Report on Form 8-K are listed in the Exhibit Index that follows. The Exhibit Index and the Exhibits listed therein are incorporated herein by this reference. |
IMMUCELL CORP /DE/ ExhibitEX-99.1 2 f8k081017ex99i_immucellcorp.htm LETTER OF RESIGNATION FROM DR. RHODES TO THE COMPANY DATED AUGUST 10,…To view the full exhibit click here
About ImmuCell Corporation (NASDAQ:ICCC)
ImmuCell Corporation is an animal health company. The Company operates in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries segment. The Company has developed products that provide immediate immunity to newborn dairy and beef cattle, and is developing product line extensions of its existing products that address mastitis. The Company’s lead product, First Defense, is manufactured from cows’ colostrum utilizing its vaccine and milk protein purification technologies. Its Wipe Out Dairy Wipes are made from a non-woven fabric that allows for a vigorous cleaning. It also developed California Mastitis Test (CMT), which is used for bulk tank, as well as individual cow sample monitoring and is used to determine which quarter of the udder is mastitic. Its product development initiative is Mast Out, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows.
